Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization

Endocrinology

Volumn 148, Issue 1, 2007, Pages 411-421

  Durán Prado, Mario ^a   Bucharles, Christine ^b   Gonzalez, Bruno J ^b   Vázquez Martínez, Rafael ^a   Martínez Fuentes, Antonio J ^a   García Navarro, Socorro ^a   Rhodes, Simon J ^c   Vaudry, Hubert ^b   Malagón, María M ^a   Castaño, Justo P ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITÉ DE ROUEN   (France)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FORSKOLIN; GROWTH HORMONE; L 779976; L 796778; L 797591; L 803087; L 817818; OCTREOTIDE; SEGLITIDE; SOMATOSTATIN 12; SOMATOSTATIN 13; SOMATOSTATIN 14; SOMATOSTATIN 2; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CHO CELL; DIMERIZATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CALCIUM; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CRICETULUS; CYCLIC AMP; DIMERIZATION; ENDOCYTOSIS; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HORMONE ANTAGONISTS; NEUROPEPTIDES; OCTREOTIDE; PEPTIDES, CYCLIC; PITUITARY GLAND; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SUS SCROFA;

EID: 33845869338     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0920     Document Type: Article

References (55)

1. Moller LN, Stidsen CE, Hartmann B, Holst JJ 2003 Somatostatin receptors. Biochim Biophys Acta 1616:1-84
2. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W 2004 Regulation and function of somatostatin receptors. J Neurochem 89:1057-1091
3. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S 1992 Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89:251-255
4. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
5. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V 1992 Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 311:290-294
6. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C 2003 Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999-1017
7. Grant M, Collier B, Kumar U 2004 Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J Biol Chem 279:36179-36183
8. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V, Schulz S 2001 Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027-14036
9. Grant M, Patel RC, Kumar U 2004 The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. J Biol Chem 279:38636-38643
10. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S 2002 Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 277:19762-19772
11. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC 2000 Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157
12. Prevost G, Benamouzig R, Veber N, Fajac A, Tatoud R, Degeorges A, Eden P 1997 The somatostatin receptor subtype 2 is expressed in normal and tumoral human tissues70. Cancer Detect Prev 21:62-70
13. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A 2005 Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68:90-101
14. Ren SG, Taylor J, Dong J, Yu R, Culler MD, Melmed S 2003 Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab 88:4239-4245
15. Parmar RM, Chan WW, Dashkevicz M, Hayes EC, Rohrer SP, Smith RG, Schaeffer JM, Blake AD 1999 Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Biochem Biophys Res Commun 263:276-280
16. Bossis I, Porter TE 2001 Identification of the somatostatin receptor subtypes involved in regulation of growth hormone secretion in chickens. Mol Cell Endocrinol 182:203-213
17. Schonbrunn A, Gu YZ, Dournard P, Beaudet A, Tannenbaum GS, Brown PJ 1996 Somatostatin receptor subtypes: specific expression and signaling properties. Metabolism 45:8-11
18. Chen L, Fitzpatrick VD, Vandlen RL, Tashjian Jr AH 1997 Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells. J Biol Chem 272:18666-18672
19. Koenig JA, Kaur R, Dodgeon I, Edwardson JM, Humphrey PP 1998 Fates of endocytosed somatostatin sst2 receptors and associated agonists. Biochem J 336(Pt 2):291-298
20. Hipkin RW, Wang Y, Schonbrunn A 2000 Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor. J Biol Chem 275:5591-5599
21. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, Schulz S 2004 Differential β-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279:21374-21382
22. Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW 1990 Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 31:1501-1509
23. Hofland LJ, Lamberts SW 2003 The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24:28-47
24. Ginj M, Chen J, Walter MA, Eltschinger V, Reubi JC, Maecke HR 2005 Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clin Cancer Res 11:1136-1145
25. Castaño JP, Delgado-Niebla E, Duran-Prado M, Luque RM, Sanchez-Hormigo A, Gracia-Navarro F, Garcia-Navarro S, Kineman RD, Malagon MM 2005 New insights in the mechanism by which SRIF influences GH secretion. J Endocrinol Invest 28:10-13
26. Luque RM, Duran-Prado M, Garcia-Navarro S, Gracia-Navarro F, Kineman RD, Malagon MM, Castaño JP 2006 Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion. Endocrinology 147:2902-2908
27. Matsumoto K, Yokogoshi Y, Fujinaka Y, Zhang C, Saito S 1994 Molecular cloning and sequencing of porcine somatostatin receptor 2. Biochem Biophys Res Commun 199:298-305
28. Luque RM, Park S, Peng XD, Delgado E, Gracia-Navarro F, Kineman RD, Malagon MM, Castaño JP 2004 Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA. J Mol Endocrinol 32:437-448
29. Fombonne J, Csaba Z, von Boxberg Y, Valayer A, Rey C, Benahmed M, Dournaud P, Krantic S 2003 Expression of somatostatin receptor type-2 (sst2A) in immature porcine Leydig cells and a possible role in the local control of testosterone secretion. Reprod Biol Endocrinol 1:19
30. Goddard I, Bauer S, Gougeon A, Lopez F, Giannetti N, Susini C, Benahmed M, Krantic S 2001 Somatostatin inhibits stem cell factor messenger RNA expression by Sertoli cells and stem cell factor-induced DNA synthesis in isolated seminiferous tubules. Biol Reprod 65:1732-1742
31. Krantic S, Benahmed M 2000 Somatostatin inhibits follicle-stimulating hormone-induced adenylyl cyclase activity and proliferation in immature porcine Sertoli cell via sst2 receptor. Biol Reprod 62:1835-1843
32. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A 2002 A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20:87-90
33. Castaño JP, Torronteras R, Ramirez JL, Gribouval A, Sanchez-Hormigo A, Ruiz-Navarro A, Gracia-Navarro F 1996 Somatostatin increases growth hormone (GH) secretion in a subpopulation of porcine somatotropes: evidence for functional and morphological heterogeneity among porcine GH-producing cells. Endocrinology 137:129-136
34. Ramirez JL, Gracia-Navarro F, Garcia-Navarro S, Torronteras R, Malagon MM, Castaño JP 2002 Somatostatin stimulates GH secretion in two porcine somatotrope subpopulations through a cAMP-dependent pathway. Endocrinology 143:889-897
35. Leroux P GB, Bucharles C, Vaudry H 1991 Autoradiographic study of somatostatin receptors in the rat cerebellum. In: McConn, ed. Methods in neuroscience. 5th ed. San Diego: Academic Press; 538
36. Farhan H, Korkhov VM, Paulitschke V, Dorostkar MM, Scholze P, Kudlacek O, Freissmuth M, Sitte HH 2004 Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J Biol Chem 279:28553-28563
37. Vilardaga JP, Bunemann M, Krasel C, Castro M, Lohse MJ 2003 Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 21:807-812
38. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WW, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM 1998 Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282:737-740
39. O'Carroll AM, Raynor K, Lolait SJ, Reisine T 1994 Characterization of cloned human somatostatin receptor SSTR5. Mol Pharmacol 46:291-298
40. Hershberger RE, Newman BL, Florio T, Bunzow J, Civelli O, Li XJ, Forte M, Stork PJ 1994 The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways. Endocrinology 134:1277-1285
41. Strnad J, Hadcock JR 1995 Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem Biophys Res Commun 216:913-921
42. Carruthers AM, Warner AJ, Michel AD, Feniuk W, Humphrey PP 1999 Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Gαs proteins. Br J Pharmacol 126:1221-1229
43. Saveanu A, Gunz G, Dufour H, Caron P, Fina F, Ouafik L, Culler MD, Moreau JP, Enjalbert A, Jaquet P 2001 Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. J Clin Endocrinol Metab 86:140-145
44. Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G 2002 SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146:707-716
45. Strnad J, Eppler CM, Corbett M, Hadcock JR 1993 The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation. Biochem Biophys Res Commun 191:968-976
46. Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan Y, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett AA 1998 Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA 95:10836-10841
47. Nunn C, Langenegger D, Hurth K, Schmidt K, Fehlmann D, Hoyer D 2003 Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists. Eur J Pharmacol 465:211-218
48. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD 1996 Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638
49. Wahid ST, Marbach P, Stolz B, Miller M, James RA, Ball SG 2002 Partial tachyphylaxis to somatostatin (SST) analogues in a patient with acromegaly: the role of SST receptor desensitisation and circulating antibodies to SST analogues. Eur J Endocrinol 146:295-302
50. Cvejic S, Devi LA 1997 Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964
51. Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC 2006 Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47:502-511
52. Elberg G, Hipkin RW, Schonbrunn A 2002 Homologous and heterologous regulation of somatostatin receptor 2. Mol Endocrinol 16:2502-2514
53. Brasselet S, Guillen S, Vincent JP, Mazella J 2002 β-Arrestin is involved in the desensitization but not in the internalization of the somatostatin receptor 2A expressed in CHO cells. FEBS Lett 516:124-128
54. Schwartkop CP, Kreienkamp HJ, Richter D 1999 Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (δ349). J Neurochem 72:1275-1282
55. Hipkin RW, Friedman J, Clark RB, Eppler CM, Schonbrunn A 1997 Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272:13869-13876